Journal
CELL CYCLE
Volume 7, Issue 17, Pages 2674-2681Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/cc.7.17.6523
Keywords
acanthosis nigricans; benign; epidermal nevi; FGFR3; mosaicism; mutations; oncogene; PIK3CA; seborrheic keratoses; skin
Categories
Funding
- Nacional de I+D [SAF2007-60860, Consolider ONCOBIO]
- Ministerio de Ciencia e Innovacion, Madrid, Spain
Ask authors/readers for more resources
Somatic oncogenic activating mutations in FGFR3 and/or PIK3CA have recently been described in benign epithelial cutaneous lesions that never progress to malignancy (seborrheic keratoses and epidermal nevi). The same mutations have been observed in malignant neoplasms from other tissues (bladder carcinoma, cervix cancer, colorectal cancer, myeloma). However, many of the above-mentioned epithelial benign cutaneous tumors do not harbour mutations in FGFR3 or PIK3CA. In this review, we focus on new candidate genes for discovery and we outline the potential of the skin as a model to achieve a better understanding of cancer biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available